Company / Interest Expense per Share
ResMed Interest Expense per Share History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.17
FY2021
5-year range
$0.17 / $0.17
FY2017-FY2021
Trend
-41.1%
vs FY2020
Sector context
#34 of 40
Health Care
What the data says
ResMed's interest expense per share of $0.17 is lower than 85% of companies in the Health Care sector (FY2021). Interest Expense per Share has fluctuated over the past 6 years, ranging from $0.08 in FY2016 to $0.28 in FY2020.
Based on SEC 10-K filings.
0.17 in FY2021 with a 5-year CAGR of +15.7%.
Improved from $0.25 to $0.17 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -6.0%
- 5-Year CAGR
- +15.7%
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 40This company $0.17 Sector average $1.56
▼
-89.4% below sector average
Key checks
Key Insights
- In FY2021, interest expense per share decreased 41.1% year-over-year.
- Ranks #34 out of 40 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2020.
- Lowest interest expense per share in the period was in FY2016.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $0.17 | -41.1% |
| FY2020 | $0.28 | +10.9% |
| FY2019 | $0.25 | +27.1% |
| FY2018 | $0.20 | -0.6% |
| FY2017 | $0.20 | +151.6% |
| FY2016 | $0.08 | +93.7% |
As of FY2021 · SEC 10-K · Updated Feb 28, 2026